Lisa Adler, VP of corporate communications for Millennium Pharmaceuticals through its 2008 acquisition by Takeda Pharmaceutical Company, has moved to publicly traded Ironwood Pharmaceuticals in a senior VP role.
Cambridge, Mass.-based Ironwood's flagship drug is Linaclotide (marketed as Linzess), an irritable bowel syndrome treatment approved by the FDA in 2012 and granted patent protection in February 2014.
Adler, who exits Millennium after 10 years, did agency stints at Porter Novelli (VP) and Ogilvy's Feinstein Kean Healthcare (EVP) around three years in PR in Johnson & Johnson's US pharmaceuticals group.
Adler's appointment was announced with new Ironwood CFO Thomas Graney, a one-two punch that is a key part of the company's plan to build a "leading GI company," said CEO Peter Hecht.
Ironwood posted a $60.4M net loss in the second quarter as Linzess sales ticked up 3% to $62.7M.
Business leaders will face challenges in the upcoming year, some of which will come as a complete surprise, or beyond anyone's imagination.
Teneo has hired Philipp Grontzki, who is a 20-year veteran of corporate communications and financial journalism, as a managing director in its strategy and communications group.
Rowan Benecke, who co-founded Zeno Group and helmed Burson-Marsteller's tech practice, has joined McKinsey & Co as director of communications for North America.
BCW has named Golin's Matt Coldagelli EVP and leader of its corporate affairs practice in Chicago.
Abby Bailey, who headed corporate communications for Fedex in its Middle East, India and Africa region, has joined Teneo as managing director in Dubai.
Have a comment? Send it to 
No comments have been submitted for this story yet.